Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
Recruiting · 2 sites across 2 states
Always free
Study care at no cost to you
For your time and travel
Many studies pay you back
Most need no insurance or papers
Legal status usually isn't required; we'll tell you each study's requirements
Interpreters available
Ask for your language
Your choice
Voluntary — you can stop anytime
What is this study?
evaluation of the EndoZip system procedure compared to the Apollo ESG procedure in obese patients.
It is , overseen by an independent and licensed medical staff.
Read the full clinical description
evaluation of the EndoZip system procedure compared to the Apollo ESG procedure in obese patients.
Who this study is looking for
In plain language, from the study's own rules. The study team confirms the full details with you — this isn't a final yes or no.
✅ You may be able to join if…
- •Age 21 to 65
- •BMI between 30 and 50 kg/m² (BMI is a measure based on height and weight)
- •You have tried non-surgical weight-loss methods before but they did not work
- •You are willing to follow the study’s diet, behavior program, lab tests, questionnaires (IWQOL), and follow-up visits
- •For women who can become pregnant: you agree to use birth control
- •You can travel to the study site for routine follow-up visits and you can give informed consent
🚫 You may not be able to join if…
- •History of certain stomach/upper GI surgeries (foregut or GI surgery, except uncomplicated gallbladder removal or appendectomy)
- •Prior bariatric (weight-loss) surgery
- •A current or likely need for insulin for diabetes (insulin-dependent diabetes, or Type 2 diabetes likely to need insulin in the next 12 months, or HbA1c is 9 or higher)
- •Diabetes using GLP-1 meds with recent weight-loss changes that meet the study’s stopping/regain rules
- •Pregnant or breastfeeding
- •Severe stomach/esophagus conditions that could block the endoscope or cause bleeding (examples listed include varices, Barrett’s esophagus, ulcers, cancer, strictures/diverticulum, achalasia, and severe reflux/large hiatal hernia)
- •INR above 1.5 or use anticoagulation (blood-thinning) therapy
- •Severe heart/lung disease (examples listed include recent heart attack, poorly controlled hypertension, congestive heart failure, serious arrhythmia/unstable coronary disease, COPD, pneumonia, or cancer)
Are you a good fit?
Simplified highlights. The study team always confirms the full details with you.
- ✓Adults roughly 21–65
- ✓A BMI around 30 or higher
- ✓Have Obesity / overweight or Type 2 diabetes or High blood pressure
- !Some conditions may not be a fit: Heart / cardiovascular disease, COPD (chronic lung disease)
- !Not for people who are pregnant or breastfeeding
- !May require a break from current GLP-1 medications
What to expect, step by step
- 1
Usually a few weeks
The study team checks whether the study is a good fit for you, with a visit and sometimes lab tests. You can ask any questions before deciding.
- 2
Treatment
If you join and choose to continue, you receive the study treatment and are watched closely by medical staff.
- 3
Follow-up
After treatment, the team checks on your health and confirms the visit schedule with you. You can leave the study at any point.
Has this treatment been tested before?
The study team can share what safety testing has been done so far.
What you need to know before you apply
What is this study testing?+
evaluation of the EndoZip system procedure compared to the Apollo ESG procedure in obese patients.
Is it safe? Who makes sure of that?+
This is a research study. Every study is reviewed and monitored by an independent ethics board (called an IRB) whose job is to protect participants, and care is overseen by licensed medical staff. You'll be told the known risks before you agree to anything, and you can stop at any time.
Will I get a placebo instead of the real treatment?+
Some studies compare a treatment against a placebo (an inactive version), and some don't. If this one does, the study team will explain your chances of receiving the active treatment before you decide. Nothing is hidden from you.
I take a GLP-1 medication (like Ozempic or Wegovy). Can I still join?+
Maybe. This study may ask you to pause certain weight or diabetes medications for a period of time (a 'washout') before joining, or it may be looking for people not currently on them. The coordinator will review your medications with you — don't stop any medication on your own.
Does it cost anything? Will I be paid?+
Study-related care is provided at no cost to you. Some studies also pay for your time; the coordinator can tell you if this one does. You should never be asked to pay to take part.
Do I need insurance? Will anyone ask about my immigration status?+
No. You do not need health insurance to take part in a research study, and you will not be asked about your immigration status to join. Taking part is about whether you're a medical fit for the study.
What if English isn't my first language?+
You have the right to understand everything before you agree. Study sites can often provide materials or an interpreter in your language — you can ask the coordinator for one.
Is my information private?+
Yes. Your health information is only shared with the study sites you choose to be contacted by, and only to help match and enroll you. It is never sold, and you can ask us to delete it at any time.
Some requirements (like specific lab values or timing) are confirmed directly by the study team, not by us.
Source: ClinicalTrials.gov · NCT07090005 · Locations: California · New York